Cargando…

1617 Safety, Tolerability, and Antiretroviral Activity of Raltegravir in HIV-1 Infected Russian Children and Adolescents – a 24 Week Study

Detalles Bibliográficos
Autores principales:	Teppler, Hedy, Shuldyakov, Andrey, Gankina, Natalia, Kulagin, Valeriy, Nagimova, Firaya, Shimonova, Tatiana, Sonin, Dmitriy, Sotnikov, Vladimir, Zakharova, Natalia, Homony, Brenda, Wang, Deng, Moshkovich, Grigoriy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782091/ http://dx.doi.org/10.1093/ofid/ofu052.1163

Ejemplares similares

1575 A 28-day high-dose safety and pharmacokinetics study of raltegravir in healthy subjects
por: Krishna, Rajesh, et al.
Publicado: (2014)

936 Tolerability, Adherence and Completion of New Occupational HIV Post-Exposure Prophylaxis Regimens (Tenofovir + Emtricitabine and Raltegravir)
por: Bock, Izona, et al.
Publicado: (2014)

A Health Literate Patient-focused Approach to the Redesign of the Raltegravir (ISENTRESS) Pediatric Kit and Instructions for Use
por: Mills, Alexander, et al.
Publicado: (2021)

1529 Raltegravir Plus Tenofovir DF and Emtricitabine for Non-occupational Postexposure Prophylaxis (nPEP): African-Americans are at Higher Risk of Non-Completion of nPEP
por: Vigil, Karen J., et al.
Publicado: (2014)

542 A Unique Non-Nucleoside RT Inhibitor Resistance Mutation in Epidemic Russian Subtype A HIV-1 Strains
por: Kolomeets, Anna, et al.
Publicado: (2014)

695 Bone and Joint Infections in Children in the Era of Community- Acquired Meticillin- Resistant S. aureus
por: Rosanova, Maria Teresa, et al.
Publicado: (2014)

Long-Term Safety from the Raltegravir Clinical Development Program
por: Teppler, Hedy, et al.
Publicado: (2011)

Maternal–Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing
por: Lommerse, Jos, et al.
Publicado: (2019)

Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial
por: Cahn, Pedro, et al.
Publicado: (2018)

304 Methicillin-resistant Staphylococcus aureus in Ohio EMS providers: A statewide cross-sectional study
por: Orellana, Robert, et al.
Publicado: (2014)

113 Procedure-specific Surgical Site Infection (SSI) Prevalence Widely Varies within Certain NHSN (National Healthcare Safety Network) Surgery Groups
por: Saeed, Mohammed, et al.
Publicado: (2014)

1124 Clinical characteristics of adult patients with influenza B and A infections during 2013/2014 flu season
por: Ahn, Mi Young, et al.
Publicado: (2014)

1543 Counting the Costs of Falsely Labeling Patients as HIV-Positive in Tahoua Region, Niger
por: Megill, Matthew
Publicado: (2014)

538 A Retrospective Study to Evaluate the Safety of Switching Antiretroviral Therapy (ART) to Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine (RPV/TDF/FTC) STR in Virologically Suppressed HIV-Infected Patients
por: Monczor, Ana, et al.
Publicado: (2014)

1067 Multi-Attribute Ranking Tool for Vaccines: Strategic Priority Setting to Support Vaccine Development
por: Madhavan, Guruprasad, et al.
Publicado: (2014)

1535 Knowledge, Practice, and Attitudes of University of California San Diego Medical Students with Regard to HIV and HIV Screening
por: Katsivas, Theodoros, et al.
Publicado: (2014)

1550 Can We Re-engage Patients with HIV Who Are Lost to Care? A Pilot Study in a Large Urban HIV Clinic
por: Lee, Dong Heun, et al.
Publicado: (2014)

473 Comparison of MicroScan System Prompt and Turbidity Methods for Measuring Vancomycin Minimum inhibitory concentration (MIC) against Methicillin-resistant Staphylococcus aureus (MRSA) with MIC of 2ug/ml, the Clinical Implications and economic impact of using alternative antimicrobial agents to vancomycin for MRSA with possible MIC of 2ug/ml
por: Kamran, Amir, et al.
Publicado: (2014)

870 The Epidemiology of CAUTI due to Candida spp. in the Intensive Care Unit (ICU) - Infection or Colonization?
por: Tashtoush, Nader, et al.
Publicado: (2014)

1454 Antifungal Susceptibility Patterns of a Global Collection of Fungal Isolates and Polysorbate-80 Effect on the Susceptibility of the Antifungal Classes
por: Castanheira, Mariana, et al.
Publicado: (2014)

766 Clinical Features and Outcome of Patients with Middle East Respiratory Syndrome-Coronavirus (MERS-CoV) Infection
por: Alraddadi, Basem, et al.
Publicado: (2014)

1624 Risk Factors for Hospital-Acquired Clostridium difficile
por: Knepper, Bryan, et al.
Publicado: (2014)

1551 The Patient-Centered Medical Home: A Reality for HIV Care in Nigeria
por: Ahonkhai, Aimalohi, et al.
Publicado: (2014)

1663 Imported Exotic Infectious Diseases in Columbia, Missouri
por: Regunath, Hariharan, et al.
Publicado: (2014)

1627 Diagnostic Accuracy of Loop-Mediated Isothermal DNA Amplification (LAMP) Assay for Detection of Clostridium difficile Infection (CDI): a Meta-Analysis
por: Lloyd, Aaron, et al.
Publicado: (2014)

1681 Randomized Clinical Trial of the Recovery of Probiotics Lactobacillus rhamnosus GG (LGG) and Bifidobacterium animalis subspecies lactis (BB-12) from the Gastrointestinal (GI) Tract of Healthy Volunteers
por: Poutsiaka, Debra D., et al.
Publicado: (2014)

898 The Impact of State Mandated Healthcare-Associated Infection Reporting on Infection Prevention and Control Departments in Acute Care Hospitals: Results from a National Survey
por: Herzig, Carolyn, et al.
Publicado: (2014)

910 Seasonal Variation of Surgical Site Infections Following Common Procedures
por: Durkin, Michael J., et al.
Publicado: (2014)

1337 Obesity, Diabetes, and the Risk of Invasive Group B Streptococcal Disease in Non-Pregnant Adults
por: Pitts, Samantha, et al.
Publicado: (2014)

767 Association of Mortality with Leukocyte Distribution in Crimean-Congo Hemorrhagic Fever: Twelve Years Experience in A Retrospective Case Control Study
por: Bastug, Aliye, et al.
Publicado: (2014)

869 Impact of Changes in the NHSN Catheter-Associated Urinary Tract Infection (CAUTI) Definition on the Frequency and Epidemiology of CAUTIs in Intensive Care Units (ICUs)
por: Neelakanta, Anupama, et al.
Publicado: (2014)

388 Antibiotic Stewardship in the Neonatal Intensive Care Unit (NICU): Metrics Matter!
por: Cantey, Joseph, et al.
Publicado: (2014)

1049 Evaluating the Population Impact of HPV Vaccine on High Grade Cervical Intraepithelial Neoplasia Rates in an Era of Decreasing Screening
por: Patel, Deven, et al.
Publicado: (2014)

682 Microbiology and Antibiotic Treatment among Injection Drug Users and Non-Injection Drug Users Hospitalized with Acute Bacterial Skin and Skin Structure Infection
por: Jenkins, Timothy, et al.
Publicado: (2014)

1534 Missed Opportunities for HIV Diagnosis in a New Orleans Area Health System
por: Downing, Asia, et al.
Publicado: (2014)

817 The Association between Asthma and Invasive Pneumococcal Disease: A Nationwide Study in Korea
por: Kwak, Byung Ok
Publicado: (2014)

1579 Administering Influenza Vaccine to Patients with Human Immunodeficiency Virus (HIV): Does Timing Matter?
por: Glinka, Elizabeth R., et al.
Publicado: (2014)

939 Electronic Mail (email) Reminders as an Alternative to Directly Observed Therapy (DOT) for the Treatment of Latent Tuberculosis Infection (LTBI) using 12 weeks of Rifapentine and INH (R plus I) for Healthcare Workers (HCWs)
por: Lacaille, Sherard N.J., et al.
Publicado: (2014)

1676 Salivary Levels of Streptococcus mutans in Individuals with Temporomandibular Disorders
por: Galvão-Moreira, Leonardo Victor, et al.
Publicado: (2014)

272 Characteristics of USA500/Iberian Methicillin-Resistant Staphylococcus aureus (MRSA) Invasive Disease
por: Melendez, Andre G., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6k3r24ddvnro7ge5h7isuae89j